United Arab Emirates Pemetrexed Market Size & Outlook, 2025-2033


United Arab Emirates Pemetrexed Market Insights

  • Reed Intelligence analysis indicates that the United Arab Emirates Pemetrexed Market size, valued at USD 96.01 Million in 2024, is expected to expand to USD 111.03 Million by 2033.
  • The United Arab Emirates market is forecasted to expand at a CAGR of 1.61% spanning 2026–2033.
  • Malignant Pleural Mesothelioma held the leading position among By Application segments in 2024, based on market size.
  • Malignant Pleural Mesothelioma is projected to post the fastest growth rate, sustaining its position as the most attractive By Application segment during the forecast horizon.

Other Key Findings


  • United Arab Emirates contributed 4.1% to the global Pemetrexed Market size in 2024.
  • By 2033, United States is forecasted to remain the largest global market for Pemetrexed Market.
  • In Middle East and Africa, United Arab Emirates is projected to capture the leading share of market size by 2033.
  • Among Middle East and Africa markets, Nigeria is expected to post the fastest growth, reaching USD 13.89 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 96.01 Million
Market Size In 2033 USD 111.03 Million
Largest segment Malignant Pleural Mesothelioma
Units Revenue in USD Million
CAGR 1.61% (2025-2033)
Segmnetation Covered
By Application
  1. Malignant Pleural Mesothelioma
  2. Non-Squamous NSCLC
By End-User
  1. Hospitals
  2. Oncology Centers
  3. Online Pharmacies
  4. Offline Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends